Mccurtain Memorial Medical Management, INC.

Mccurtain Memorial Medical Management, INC. was paid $5.79M by Medicaid between Oct 2018 and Dec 2024, across 76 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.

33Billing provider infoMCCURTAIN MEMORIAL MEDICAL MANAGEMENT, INC.
IDABEL, OK 74745

33aNPI1063900975assigned 04/26/2018

33bProvider typeCritical Access Hospital

28Total paid$5.79M

24GClaims79,793

24DCodes billed76

24AFirst – last monthOct 2018 – Dec 2024

Compared with peers

Next to other Critical Access Hospital providers in Oklahoma

Rank by total paid#2 of 40

Median peer was paid$427K

This provider vs. median14×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	2,320	$124K
2019	13,357	$775K
2020	11,449	$725K
2021	9,222	$828K
2022	15,821	$1.29M
2023	19,066	$1.41M
2024incomplete	8,558	$640K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	33%	12,061	11,891	$1.91M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	27%	6,951	6,798	$1.59M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	19%	3,836	3,744	$1.10M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	4.0%	2,004	1,958	$232K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	2.7%	3,274	3,225	$158K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	2.2%	2,485	2,404	$130K
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.4%	880	870	$82K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	1.3%	5,397	2,771	$77K
80053	Comprehensive metabolic panel	1.1%	6,765	6,535	$64K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.0%	682	657	$59K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	7,118	6,878	$49K
96375	Therapeutic injection; each additional sequential IV push	<1%	1,284	1,239	$47K

64 more codes

36415	Collection of venous blood by venipuncture	<1%	8,059	$41K
71045	Radiologic examination, chest; single view	<1%	3,255	$37K
70450	Computed tomography, head or brain; without contrast material	<1%	577	$34K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	3,271	$20K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	177	$15K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	176	$14K
87430		<1%	942	$13K
96361	Intravenous infusion, hydration; each additional hour	<1%	433	$13K
81001		<1%	4,350	$12K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	125	$11K
86756		<1%	697	$10K
74178		<1%	48	$9K
71046	Radiologic examination, chest; 2 views	<1%	539	$8K
80305		<1%	704	$7K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	67	$6K
84484		<1%	504	$6K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	111	$5K
83880		<1%	149	$5K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	28	$4K
84443	Thyroid stimulating hormone (TSH)	<1%	162	$2K
87086	Culture, bacterial; quantitative colony count, urine	<1%	302	$2K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	128	$2K
83605		<1%	162	$2K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	328	$1K
82550		<1%	236	$1K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	19	$999.84
82553		<1%	83	$952.50
72125	Computed tomography, cervical spine; without contrast material	<1%	13	$911.28
84703		<1%	105	$726.07
76813		<1%	14	$723.80
83735		<1%	111	$653.93
81025		<1%	86	$562.90
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	81	$450.75
83690		<1%	58	$348.03
86850		<1%	15	$338.91
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	51	$320.25
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	13	$278.46
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	12	$259.30
85610		<1%	67	$250.26
83036	Hemoglobin; glycosylated (A1C)	<1%	29	$224.64
86696		<1%	14	$223.73
J0780	Injection, prochlorperazine, up to 10 mg	<1%	104	$195.36
87040		<1%	18	$194.40
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	101	$189.55
86762		<1%	14	$166.40
86695		<1%	14	$164.22
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	169	$158.03
85730		<1%	28	$153.57
85027		<1%	25	$145.92
82728		<1%	14	$145.44
87186		<1%	14	$130.73
83550		<1%	14	$108.78
87077		<1%	13	$107.85
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	28	$94.63
J3475	Injection, magnesium sulfate, per 500 mg	<1%	12	$88.80
83540		<1%	14	$80.50
82247		<1%	17	$75.99
84100		<1%	14	$59.22
86592		<1%	14	$53.20
86901		<1%	16	$39.90
86900		<1%	16	$37.24
85007		<1%	12	$35.64
J1170	Injection, hydromorphone, up to 4 mg	<1%	14	$8.32
J7510	Prednisolone oral, per 5 mg	<1%	70	$1.20

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCAVE, CHARLES (CFO)